InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
2
T+90 hit rate
67%
T+90 mean return
+4.6%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Leversage Jill, Director. Insider active across 1 company, notably Aurinia Pharmaceuticals Inc.. Cumulatively, 9 filings have been recorded. Breakdown: 4 buys · 2 sells. Total volume traded: €182k. Activity tracked since 11 May 2021. The latest transaction was filed on 21 November 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations9 total
12,135 shares0Common SharesSEC:0001600620-24-000124:0
5,610 shares@ US$5.7416.3% of flowCommon StockSEC:0001600620-24-000072:0
8,733 sharesCommon StockSEC:0001600620-23-000017:0
9,310 shares0Common StockSEC:0001600620-23-000017:1
4,815 shares@ US$11.2627.7% of flowCommon StockSEC:0001600620-23-000017:2
1,600 shares@ US$20.0455.7% of flowCommon StockSEC:0001628280-21-025130
Ideal exit: 9 Sept 2022 (T+270)
1,600 shares@ US$20.040.0013% mcap27.8% of flowCommon StockSEC:0001628280-21-025130:0
Ideal exit: 9 Sept 2022 (T+270)
2,500 shares@ US$10.955722.2% of flowCommon StockSEC:0001628280-21-010018
Ideal exit: 5 Feb 2022 (T+270)
2,500 shares@ US$10.95570.0011% mcap22.2% of flowCommon StockSEC:0001628280-21-010018:0
Ideal exit: 5 Feb 2022 (T+270)
9 of 9 declarations
About Leversage Jill
Jill Leversage is a Board Member at Aurinia Pharmaceuticals Inc. She plays a key role in the governance of the company and in strategic decision-making. Her expertise in the pharmaceutical sector is valuable to the board.
